A CLINICAL AND COMPARATIVE STUDY OF PIPPALI GHRIT AND PITTANTAK YOG ON AMLAPITTA
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Reduction in symptoms of Amlapitta.
研究概览
简要总结
Amlapitta is a clinical condition which has become a common problem for most of the people in this modern era. Due to changed life style, increased pace of life, stress as well as changes in food habits. The prevalence rate of gastritis in india is around 10 millions. The risk factors like spicy food ,alcohol,aspirin,other NSAID’s ,or any gastric mucosa by inhibiting prostaglandins, gastric bi-carbonates and mucous secretions and alters the mucosal micro circulation.
This produces symptom like heart burn, sour belching, acid eructation, anorexia and nausea. This leads to acute gastritis and if left unattended in the chronic stage it leads to gastric or duodenal ulcers, followed by perforation if untreated. The remedies in biomedicine are acid suppressive agents like H2 receptors antagonists, proton- pump inhibiters etc. These are working temporarily without any permanent solution as well as having adverse effects after long standing usage. Hence we shall consider the chikista sutra kaphapittahara vidhi described by Yogaratnakar to overcome the disease and the selected drug is the Pippali ghrit described by Chakradatta to overcome the disease and the selected drug Pippali ghrit containing pippali kawath, pippali kalak and gou ghrit and Pittantak yog containing Sitopala, Amrit dhara, Sudh Savaran gairik having seetvirya, madhura rasa and pittasamakaand agnidipaka guna.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 16.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Patient between 16years to 60years.
- •2.Patients of classical Amlapitta symptoms, irrespective of gender, caste, occupation and economic status.
- •3.Amlapitta of any dosha anubandha (associated doshah).
排除标准
- •1.Patient below 16 and above 60 years of age.
- •2.Patients with complication of acute or chronic gastritis like peptic ulcer any secondary infections or syndromes and medical emergencies.
- •3.Pregnant women or lactating mothers.
- •5.Patient along with diabetes, HTN,COPD, Malignancy.
- •6.Complication which intervenes the course of treatment.
- •7.Patient on chemo and radiotherapy for malignancy.
结局指标
主要结局
Reduction in symptoms of Amlapitta.
时间窗: baseline, 15 days, 30 days.
次要结局
- Measurement of Amlapitta (Acidity) severity.(baseline, 15 days, 30 days)